Étiqueté : European Commission
“Les autorités compétentes de plusieurs États membres, dont l’ANSM, ont approuvé une déclaration de consensus sur la réforme du cadre réglementaire européen des dispositifs médicaux. Adressée à la Commission européenne, cette déclaration souligne l’urgence d’aborder...
On 14 October 2025, the European Commission launched the public stakeholder consultation on the ERA Act. Contributions can be submitted via the Have Your Say portal. The consultation will remain open for 12 weeks. Read the...
Every year, EU and EEA countries share information on the citizens right to cross-border healthcare gathered through National Contact Points using a standard questionnaire. The reports separate: • Healthcare subject to prior authorisation (e.g., planned...
The Commission has published 11 webinars exploring Europe’s journey toward connected and secure digital healthcare systems, through the eHealth Network, MyHealth@EU and the eHealth Network Guidelines. Each video offers expert insights on how Member States collaborate to...
HaDEA has published the Prior Information Notice Strengthening national implementation of organ transplant practices, in particular through cooperation between national authorities and professional sector associations. The subject of this call is to strengthen national implementation...
Since 1995, the European Commission has authorised the marketing of medicines across the whole European Union. Central authorisations are valid in all EU Member States and are based on rigorous scientific evaluations by the European...
Medicines are essential for strong health systems. This is why, thirty years ago, the European Union took a decisive step to strengthen public health, support innovation and reinforce the competitiveness of EU’s pharmaceutical industry by...
On 17 October 2025, the European Commission adopted an implementing regulation establishing the rules for joint clinical assessments of medical devices and in vitro diagnostic medical devices, under the Health Technology Assessment Regulation. Read the e-News...
The sixteenth meeting of the Member State Coordination Group on Health Technology Assessment set up by Regulation (EU) 2021/2282 was held on 23 October 2025 in Brussels. The meeting covered the following points: 1) Preparation...
The European Commission (EC), the Heads of Medicines Agencies (HMA) and EMA have jointly developed two new targets for clinical trials, to monitor progress against the ambition to make the European Union (EU) a more attractive destination for...